New GLP-1 Pill, Orforglipron, Helps People Lose 23 Pounds in Study
By I. Edwards HealthDay Reporter
WEDNESDAY, Aug. 27, 2025 — Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial.
The company plans to seek global regulatory approval later this year.
The study included people with overweight, obesity, and type 2 diabetes. Participants who took the highest dose of the drug (36 milligrams) lost an average of 22.9 pounds — about 10.5% of their body weight — after 72 weeks. The pill also lowered A1C levels — a measure of blood sugar control — by 1.8% on average, CNN reported.
Those results, which have not been peer-reviewed, were lower than weight loss figures announced earlier this month, when the company reported that the highest dose helped patients shed an average 27.3 pounds, or 12.4% of their body weight.
Unlike Rybelsus, the only semaglutide pill currently available, orforglipron doesn’t require strict fasting or limited water intake.
The pill offers an alternative to injections, which some people find difficult or unpleasant.
Eli Lilly says side effects were mostly mild to moderate, with upset stomach being the most common.
If approved, orforglipron could offer millions of people with obesity or type 2 diabetes another treatment option. The company is also testing whether the pill may help with other conditions, including high blood pressure and sleep apnea.
With earlier promising trial results, the company has been mass-producing the pills for months.
“That way, we’ll have adequate supply to meet demand,” Dr. Dan Skovronsky, Lilly’s chief scientific officer, told CNN.
Sources
- CNN, Aug. 26, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Breath Test For Diabetes Under Development
WEDNESDAY, Aug. 27, 2025 — Detecting diabetes might soon be as easy as breathing into a device, a new study says. An experimental breath test sorted out type 2 diabetes...
Mediterranean Diet Can Protect Against Type 2 Diabetes
TUESDAY, Aug. 26, 2025 — A Mediterranean-style diet can significantly decrease risk of type 2 diabetes in people who are overweight or obese, a new study says. People had...
2 In 3 Women Have A Lifestyle Risk Factor For Birth Defects
TUESDAY, Aug. 26, 2025 — Two-thirds of women in their child-bearing years have an increased risk for birth defects due to a lifestyle factor they can change, a new study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.